CannaCAST IL

CannaCAST IL

By Heli Dangur, Narkis TesslerScienceHealth & FitnessTechnology
Download on the App Store

CannaCAST IL episodes

  • “1 CBD-based patent - 130 potential medical indications”
    In today’s episode, we host David Bassa, a serial entrepreneur for the past 30 years in the fields of hi-tech and biotech, with an emphasis on cannabis-based pharma. His company, Stero Biotechs has been issued a CBD-based patent covering over 130 different indications. Stero Biotechs is currently conducting seven different research studies for 7 different indications, two of them in clinical trials (Chron’s disease and Urticaria, also known as hives). Stero Biotechs’s research combats the side effects of steroids, often decreasing or even eliminating steroid use while treating the relevant medical indications.
    Stero Biotech is an excellent example of Israel’s leading edge in developing Pharma based products, with Israel’s leading HMO as a shareholder, providing access to 5 million patients, 9000 physicians, 14 hospitals and significant cost-efficiency in conducting clinical trials.
    Stero Biotechs welcomes strategic collaboration opportunities, contact them through: http://sterobiotechs.com or [email protected]
    17 min
  • ”It’s all about molecules”- innovative pharma products
    In this episode, we host Nir Peles, Founder, BOD member and VP Business Development at Cannassure Therapeutics to discuss Cannassure’s cannabis-based pharma products.
    Cannassure is currently developing innovative & standardized IP protected pharma products with the ‘look and feel’ of pharma products as opposed to plants. These products address topical delivery for skin indications such as psoriasis and rheumatism, fem-tech IUD targeting women’s health issues, and a standardized pill for delivering medical cannabis.
    One of Israel’s leading cannabis producers, Cannassure produces medical-grade cannabis in a holistic integrated production system that includes an advanced indoor-aeroponic grow facility, a state-of-the-art extraction and processing facility, together with scientifically advanced R&D.
    Nir welcomes strategic collaboration opportunities, contact him through his LinkedIn profile
    Cannassure is publicly traded - TASE: CSURE,
    Visit their website: http://cannassure.life/
    16 min
  • The Molecular Method for discovering APIs for specific medical indications
    In this episode, we host Prof. Hinanit Koltai of Israel’s Volcan Research Institute to discuss innovation in molecular plant science. Prof. Koltai walks us through the Volcan Institute’s molecular method for discovering the specific combinations of cannabis compounds beneficial in the treatment of medical indications such as inflammatory bowel disease, skin cancer, and colon cancer. Results of the research on skin cancer were recently published in Oncotarget https://www.oncotarget.com/article/27528/text/
    Prof. Koltai’s research team begins with the Volcan Institute's extensive gene bank of cannabis strains from around the world and culminates in clinical trials performed in collaboration with Israel’s physicians and hospitals to validate APIs for each specific medical indication.
    To collaborate with Prof. Koltai’s research team – contact Hinanit at [email protected]
    11 min
  • COVID-19 - A revolutionary treatment approach!
    In this episode, Iris Bincovich, CEO of Innocan Pharma shares Innocan’s collaboration with Tel Aviv University to develop a novel, revolutionary approach to treat COVID-19 by using CBD loaded Exosomes. In addition to treating COVID-19, the new drug will target additional central nervous system indications. The goal is to be ready in 2021 to conduct a licensing agreement with a large pharma company.
    Additionally, Iris shared that Innocan will be launching their new line of CBD topicals, produced in Portugal and the US, during Q2 of this year, including a line of “relief and go” pain-relief topicals as well as a line of cosmetic products.
    Interested in being a distributor? Contact: [email protected]
    17 min
  • Breakthrough in Cannabis aid for Endometriosis
    In this episode, we focus on Cannabis and women’s health with Yotam Hod, CEO & Co-Founder of Lumir Labs, Gynica and Asana Bio Group.
    Yotam shares with us an exciting breakthrough in the field of endometriosis . Gynica is currently looking for global partners for licensing their evidence-based products: [email protected]
    14 min
  • What's Israel's leading edge in the cannabis industry in 2020?
    We’re excited to return to broadcasting with this episode with Nadav Gil, Partner at Deloitte Israel and leader of the Israeli Cannabis Practice.
    In our discussion, Nadav presents an overview of the opportunities the Israeli cannabis researchers and companies offer to the global cannabis market in 2020 and describes Israel’s leading edge in science and technology.
    35 min
  • Innovation in Cannabis Medicine
    In this week's CANNACAST IL episode - "Innovation in Cannabis Medicine" - we speak to two start-ups. Our first guest, Prof. Nissim Garti of LDS technologies, has developed breakthrough Lyotropic Delivery Systems. Our second guest, Dr. Haleli Sharir of Cannabics Pharmaceuticals, is developing Personalized Cannabinoid Medication.
    15 min
  • CannaCAST IL Introduction
    CannaCAST IL was formed to strengthen and empower the Medical Cannabis industry by providing international exposure to Israel’s technology, R&D and innovation.
    Meet the Podcast Moderators :
    Heli Dangur, Director of Global Business Development, Cann10
    Narkis Tessler, CEO at TeraCann and managing partner at Blue Pesto
    9 min

About CannaCAST IL

From the publisher's feed

CannaCAST IL was formed to strengthen and empower the Medical Cannabis industry by providing international exposure to Israel’s technology, R&D and innovation.